AQR Capital Management LLC Has $1.07 Million Stake in DocGo Inc. (NASDAQ:DCGO)

AQR Capital Management LLC increased its stake in shares of DocGo Inc. (NASDAQ:DCGO) by 58.5% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 344,963 shares of the company’s stock after buying an additional 127,320 shares during the period. AQR Capital Management LLC’s holdings in DocGo were worth $1,066,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Isthmus Partners LLC lifted its stake in shares of DocGo by 32.4% during the second quarter. Isthmus Partners LLC now owns 799,296 shares of the company’s stock valued at $25,000 after acquiring an additional 195,428 shares during the period. nVerses Capital LLC lifted its holdings in shares of DocGo by 151.5% in the second quarter. nVerses Capital LLC now owns 8,300 shares of the company’s stock valued at $26,000 after purchasing an additional 5,000 shares in the last quarter. Gladius Capital Management LP bought a new position in shares of DocGo during the 2nd quarter worth approximately $34,000. Nisa Investment Advisors LLC grew its position in DocGo by 693.2% in the second quarter. Nisa Investment Advisors LLC now owns 12,089 shares of the company’s stock valued at $37,000 after purchasing an additional 10,565 shares in the last quarter. Finally, SG Americas Securities LLC acquired a new stake in shares of DocGo in the second quarter valued at about $60,000. 56.44% of the stock is currently owned by institutional investors and hedge funds.

DocGo Stock Performance

NASDAQ DCGO opened at $3.26 on Friday. DocGo Inc. has a fifty-two week low of $2.75 and a fifty-two week high of $6.90. The firm’s fifty day moving average price is $3.45 and its two-hundred day moving average price is $3.35. The stock has a market cap of $331.11 million, a PE ratio of 16.30, a PEG ratio of 2.73 and a beta of 0.91.

DocGo (NASDAQ:DCGO) last announced its earnings results on Wednesday, August 7th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.01). The company had revenue of $164.95 million for the quarter, compared to the consensus estimate of $166.61 million. DocGo had a return on equity of 8.90% and a net margin of 3.97%. As a group, sell-side analysts predict that DocGo Inc. will post 0.23 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on DCGO shares. Cantor Fitzgerald reiterated an “overweight” rating and issued a $5.00 target price on shares of DocGo in a research note on Friday, September 20th. Needham & Company LLC reissued a “buy” rating and set a $7.00 price target on shares of DocGo in a research report on Thursday, August 8th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat, DocGo currently has a consensus rating of “Buy” and a consensus target price of $6.10.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.